Arquivamento definitivo - Art. 33 da LPI
#11.1.1
07/18/2023
RPI 2741
Application data
Number
112021011546Type
Filing
Publication
PCT
US2020014239 The application was abandoned: examination was not requested within the 36 months following the 01/19/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 07/18/2023. We update with every new RPI gazette, published weekly.
Applicants
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
US
Inventors
R. C. (pessoa física)
US
V. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/794,665 · 01/20/2019
US
62/844,169 · 05/07/2019
US
62/893,206 · 08/29/2019
US
62/910,284 · 10/03/2019
US
62/959,088 · 01/09/2020
Abstract
ANTAGONISTAS DE CGRP PARA TRATAMENTO DE CRISES DE ENXAQUECA.São descritos métodos de tratamento de crise de enxaqueca em pacientes que usam antagonistas de CGRP contra as crises. Também são descritos métodos para o tratamento profilático da enxaqueca.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
07/18/2023
RPI 2741
#11.1
05/02/2023
RPI 2730
#1.3
08/31/2021
RPI 2643
#1.1
06/22/2021
RPI 2633
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.